Oncology & Cancer

Trial shows how PET scans help tailor therapy for esophageal cancer

Survival results for the CALGB 80303 Trial presented today at the American Society of Clinical Oncology (ASCO) Annual Meeting 2018 demonstrate that esophageal cancer patients shown by PET scan to be non-responders to induction ...

Oncology & Cancer

Right-sided colorectal tumors: An internal radiation advantage

For patients with colorectal cancer that has metastasized to the liver, having a primary tumour on the left side, as opposed to the right side of the colon, is known to be a significant advantage in terms of treatment response.

Oncology & Cancer

More chemo drugs don't improve treatment of rare bone cancer

Osteosarcoma patients with tumors that haven't responded well to the standard chemotherapy regimen have unimproved outcomes and more side effects when given two additional drugs, a large international trial has found.

page 1 from 8